Inventor · disambiguated record
Jung-Hui Sun
Also filed as: SUN JUNG · SUN JUNG-HUI
19 granted patents·3 pending applications·246 citations·filing 1986–2007
95Inventor score
Files withDU PONT MERCK PHARMA9ERBAMONT INC4BRISTOL MYERS SQUIBB PHARMA CO3BRISTOL MYERS SQUIBB CO1DU PONT PHARM CO1
Top patents by PatentIndex Score
22 records- 0191US4888353ACarboxamides useful as antiemetic or antipsychotic agentsERBAMONT INC·Filed 1986·Granted Dec 19, 1989·35 cites·37 claims
- 0284US5206249ABis-naphthalimides containing amino-acid derived linkers as anticancer agentsDU PONT MERCK PHARMA·Filed 1991·Granted Apr 27, 1993·25 cites·6 claims
- 0383US5175173ACarboxamides useful as antiemetic or antipsychotic agentsSUN JUNG HUI·Filed 1989·Granted Dec 29, 1992·23 cites·2 claims
- 0482US5461176AProcesses for preparing bis-naphthalimides containing amino-acid derived linkersDU PONT MERCK PHARMA·Filed 1994·Granted Oct 24, 1995·28 cites·13 claims
- 0580US6667332B2Efficient process for the preparation of a factor Xa inhibitorBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Dec 23, 2003·11 cites·35 claims
- 0675US5532357AMethod for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureasDU PONT MERCK PHARMA·Filed 1995·Granted Jul 2, 1996·20 cites·11 claims
- 0773US4772459AMethod for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful thereinERBAMONT INC·Filed 1986·Granted Sep 20, 1988·21 cites·24 claims
- 0871US6747158B2Efficient process for the preparation of a factor Xa inhibitorBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Jun 8, 2004·4 cites·25 claims
- 0970US5376664AUnsymmetrical mono-3-nitro bis-naphthalimides as anticancer agentsDU PONT MERCK PHARMA·Filed 1993·Granted Dec 27, 1994·11 cites·8 claims
- 1068US5086059ABis-naphthalimides as anticancer agentsDU PONT MERCK PHARMA·Filed 1990·Granted Feb 4, 1992·24 cites·36 claims
- 1162US5925635AN-(amidinophenyl) cyclourea analogs as factor XA inhibitorsDU PONT PHARM CO·Filed 1997·Granted Jul 20, 1999·8 cites·20 claims
- 1262US5641782A3-aromatic and 3-heteroaromatic substituted bisnaphthalimidesDU PONT MERCK PHARMA·Filed 1995·Granted Jun 24, 1997·9 cites·16 claims
- 1360US5329048AProcess of preparing tetraamino intermediatesDU PONT MERCK PHARMA·Filed 1993·Granted Jul 12, 1994·6 cites·1 claims
- 1454US2004198787A1Efficient process for the preparation of a factor Xa inhibitorFiled 2004·Application pending·0 cites
- 1553US5206250ABis-naphthalimides containing amide and thioamide linkers as anticancer agentsDU PONT MERCK PHARMA·Filed 1991·Granted Apr 27, 1993·9 cites·8 claims
- 1649US2007219370A1Process for preparing n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino] -5-thiazolecarboxamide and related metabolites thereofBRISTOL MYERS SQUIBB CO·Filed 2007·Application pending·0 cites
- 1748US6521614B1N-(amidinophenyl)cyclourea analogs as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Feb 18, 2003·3 cites·48 claims
- 1840US5126364A4-amino-5-chloro-n-(2-pyrrolidinylmethyl)-2,3-dihydrobenzo[b]furan-7-carboxamide and pharmaceutical compositions containing the sameERBAMONT INC·Filed 1990·Granted Jun 30, 1992·1 cites·8 claims
- 1938US5488110AHighly water soluble bis-naphthalimides useful as anticancer agentsDU PONT MERCK PHARMA·Filed 1994·Granted Jan 30, 1996·5 cites·3 claims
- 2031US4950766APreparation of benzamides useful as antiemetic agentsERBAMONT INC·Filed 1989·Granted Aug 21, 1990·0 cites·10 claims
- 2130US5646303AMethod for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful thereinPHARMACIA INC·Filed 1988·Granted Jul 8, 1997·3 cites·1 claims
- 2226US2002048802A1Prokaryotic reverse transcriptaseFiled 1997·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →